188 related articles for article (PubMed ID: 37309797)
21. Innate immune responses in Behçet disease and relapsing polychondritis.
Shimizu J; Murayama MA; Mizukami Y; Arimitsu N; Takai K; Miyabe Y
Front Med (Lausanne); 2023; 10():1055753. PubMed ID: 37435539
[TBL] [Abstract][Full Text] [Related]
22. [Original presentation of relapsing polychondritis: four cases].
Fraisse T; Brunel AS; Arnaud E; Balducchi JP; Jourdan J; de Wazières B; Sotto A
Rev Med Interne; 2008 Oct; 29(10):801-4. PubMed ID: 18486996
[TBL] [Abstract][Full Text] [Related]
23. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist.
Sterling D; Duncan ME; Philippidou M; Salisbury JR; Kulasekararaj AG; Basu TN
J Am Acad Dermatol; 2023 Dec; 89(6):1209-1214. PubMed ID: 35121074
[TBL] [Abstract][Full Text] [Related]
24. Relapsing polychondritis or relapsing polychondritis-like symptoms associated with IgG4-RD. Case reports and review of the literature.
Gallo JR; Schmid MM; Yanzi JG; Paira SO
Mod Rheumatol Case Rep; 2022 Jan; 6(1):106-110. PubMed ID: 34595536
[TBL] [Abstract][Full Text] [Related]
25. [Auricular chondritis as first symptom of ANCA-associated vasculitis].
Pfannkuch L; Schneider U; Rudolph B; Weinerth J; Krusche M
Z Rheumatol; 2020 Nov; 79(9):902-905. PubMed ID: 32681196
[TBL] [Abstract][Full Text] [Related]
26. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.
Vitale A; Caggiano V; Martin-Nares E; Frassi M; Dagna L; Hissaria P; Sfriso P; Hernández-Rodríguez J; Ruiz-Irastorza G; Monti S; Tufan A; Piga M; Giardini HAM; Lopalco G; Viapiana O; De Paulis A; Triggianese P; Vitetta R; de-la-Torre A; Fonollosa A; Caroni F; Sota J; Conticini E; Sbalchiero J; Renieri A; Casamassima G; Wiesik-Szewczyk E; Yildirim D; Hinojosa-Azaola A; Crisafulli F; Franceschini F; Campochiaro C; Tomelleri A; Callisto A; Beecher M; Bindoli S; Baggio C; Gómez-Caverzaschi V; Pelegrín L; Soto-Peleteiro A; Milanesi A; Vasi I; Cauli A; Antonelli IPB; Iannone F; Bixio R; Casa FD; Mormile I; Gurnari C; Fiorenza A; Mejia-Salgado G; Kawakami-Campos PA; Ragab G; Ciccia F; Ruscitti P; Bocchia M; Balistreri A; Tosi GM; Frediani B; Cantarini L; Fabiani C
Semin Arthritis Rheum; 2024 Jun; 66():152430. PubMed ID: 38554594
[TBL] [Abstract][Full Text] [Related]
27. An update on VEXAS syndrome.
Al-Hakim A; Savic S
Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591
[TBL] [Abstract][Full Text] [Related]
28. [Erythema annulare centrifugum and relapsing polychondritis].
Ingen-Housz S; Venutolo E; Pinquier L; Cavelier-Balloy B; Dubertret L; Flageul B
Ann Dermatol Venereol; 2000; 127(8-9):735-9. PubMed ID: 11011166
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic
Tsuchida N; Kunishita Y; Uchiyama Y; Kirino Y; Enaka M; Yamaguchi Y; Taguri M; Yamanaka S; Takase-Minegishi K; Yoshimi R; Fujii S; Nakajima H; Matsumoto N
Ann Rheum Dis; 2021 Aug; 80(8):1057-1061. PubMed ID: 33789873
[TBL] [Abstract][Full Text] [Related]
30. A Double Hit to Ubiquitination Leading to a New Diagnosis of VEXAS Syndrome.
Pozdniakova H; Vedire A; Kadakia A; Imburgio S; Bajwa R; Gupta V; Bhatt R; Hossain MA
J Med Cases; 2023 Oct; 14(9-10):327-331. PubMed ID: 37868330
[TBL] [Abstract][Full Text] [Related]
31. VEXAS syndrome: An update.
Khitri MY; Hadjadj J; Mekinian A; Jachiet V
Joint Bone Spine; 2024 Feb; 91(4):105700. PubMed ID: 38307404
[TBL] [Abstract][Full Text] [Related]
32. Autoimmunity and Autoinflammation: Relapsing Polychondritis and VEXAS Syndrome Challenge.
Cardoneanu A; Rezus II; Burlui AM; Richter P; Bratoiu I; Mihai IR; Macovei LA; Rezus E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396936
[TBL] [Abstract][Full Text] [Related]
33. Progress and challenges in the use of blood biomarkers in relapsing polychondritis.
Liu Y; Li X; Cheng L; Zhan H; Huang Y; Li H; Li Y
Clin Exp Immunol; 2023 Jun; 212(3):199-211. PubMed ID: 36751132
[TBL] [Abstract][Full Text] [Related]
34. VEXAS syndrome: a diagnostic puzzle.
Ruffer N; Krusche M
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37532466
[TBL] [Abstract][Full Text] [Related]
35. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosum.
Dehghan N; Marcon KM; Sedlic T; Beck DB; Dutz JP; Chen LYC
Lancet; 2021 Aug; 398(10300):621. PubMed ID: 34391501
[No Abstract] [Full Text] [Related]
36. VEXAS-Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations.
Baur V; Stoevesandt J; Hueber A; Hüffmeier U; Kneitz H; Morbach H; Schultz E; Goebeler M
J Dtsch Dermatol Ges; 2023 Dec; 21(12):1456-1463. PubMed ID: 37953404
[TBL] [Abstract][Full Text] [Related]
37. Coexisting relapsing polychondritis and sarcoidosis: an unusual association.
Pasquet F; Cottin V; Sivova N; Le Scanff J; Broussolle C; Sève P
Rheumatol Int; 2010 Sep; 30(11):1507-9. PubMed ID: 19714334
[TBL] [Abstract][Full Text] [Related]
38. [Relapsing polychondritis with atypical presentation].
Sánchez Muñoz LA; Virosta Allegue M; Franco-Vicario R; Solano López D; Miguel De La Villa F
An Med Interna; 1996 Apr; 13(4):181-4. PubMed ID: 8688477
[TBL] [Abstract][Full Text] [Related]
39. A case of VEXAS syndrome manifesting as Kikuchi-Fujimoto disease, relapsing polychondritis, venous thromboembolism and macrocytic anaemia.
Lee SMS; Fan BE; Lim JH; Goh LL; Lee JSS; Koh LW
Rheumatology (Oxford); 2021 Sep; 60(9):e304-e306. PubMed ID: 33630036
[No Abstract] [Full Text] [Related]
40. Mice expressing HLA-DQ6alpha8beta transgenes develop polychondritis spontaneously.
Lamoureux JL; Buckner JH; David CS; Bradley DS
Arthritis Res Ther; 2006; 8(4):R134. PubMed ID: 16872515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
